Efficacy and safety of ibandronate in the treatment of hypercalcemia of malignancy: a randomized multicentric comparison to pamidronate

To compare the efficacy and safety of ibandronate and pamidronate in patients with hypercalcemia of malignancy (HCM). Seventy-two patients with HCM [albumin-corrected serum calcium (CSC) >2.7 mmol/l] were treated with a single infusion of ibandronate (2 or 4 mg) or pamidronate (15, 30, 60, or 90...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Supportive care in cancer 2003-08, Vol.11 (8), p.539-547
Hauptverfasser:	PECHERSTORFER, M, STEINHAUER, E. U, RIZZOLI, R, WETTERWALD, M, BERGSTRÖM, B
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Oral Aged Anti-Inflammatory Agents - administration & dosage Anti-Inflammatory Agents - adverse effects Anti-Inflammatory Agents - pharmacology Biological and medical sciences Bone Resorption Confidence intervals Diphosphonates - administration & dosage Diphosphonates - adverse effects Diphosphonates - pharmacology Drug therapy Female General and cellular metabolism. Vitamins Humans Hypercalcemia - drug therapy Hypercalcemia - etiology Male Medical sciences Middle Aged Neoplasms - complications Pharmacology. Drug treatments Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!